News

Partner companies' news

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
CELEBRATION, Fla., March 30, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— April 2022 — 454 views KMPH

Motorsport Games Reports Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 30, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today reported financial result...
Acorn Management Partners, Administrator
— April 2022 — 469 views MSGM

Motorsport Games’ rFactor 2 Becomes the Official Sim Racing Platform of Formula E
MIAMI, March 28, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 502 views MSGM

Motorsport Games Partners with Romain Grosjean to Assist in the Development of rFactor 2 and esports Events
MIAMI, March 25, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 462 views MSGM

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 478 views KMPH

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
CELEBRATION, Fla., March 21, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company or KemPharm), a specialty pharmaceutical company ...
Acorn Management Partners, Administrator
— March 2022 — 455 views KMPH

Motorsport Games to Report Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 16, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and ...
Acorn Management Partners, Administrator
— March 2022 — 405 views MSGM

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
CELEBRATION, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company, or KemPharm), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— March 2022 — 433 views KMPH

KemPharm to Report Fourth Quarter and Full-Year 2021 Results
CELEBRATION, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

Medexus to Participate in the 34th Annual Roth Conference
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleas...
Acorn Management Partners, Administrator
— March 2022 — 486 views MEDXF

Medexus Pharmaceuticals Announces Deal for Gleolan in the United States
TORONTO and CHICAGO, March 01, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that it...
Acorn Management Partners, Administrator
— March 2022 — 454 views MEDXF

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
CELEBRATION, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— February 2022 — 462 views KMPH

Motorsport Games Announces Next Gen Car For NASCAR 21: Ignition
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 493 views MSGM

Motorsport Games and Adam Breeden announce global agreement with Formula 1® to create next-level competitive socialising experience, launching in London in 2022
MIAMI, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Adam Breeden, the pioneer of competitive socialising in the UK and entrepreneurial force behind some of the...
Acorn Management Partners, Administrator
— February 2022 — 436 views MSGM

Medexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debentures
TORONTO and CHICAGO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the...
Acorn Management Partners, Administrator
— February 2022 — 451 views MEDXF

Motorsport Games Announces rFactor 2 Content Update and User Interface Refresh
MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 433 views MSGM

KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
CELEBRATION, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 447 views KMPH

KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion
CELEBRATION, Fla., Jan. 12, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 464 views KMPH

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference
CELEBRATION, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 455 views KMPH

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”
CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 486 views KMPH

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives